Apteka Portowasp. z o.o. + limited partnership
Dispensing chemist in specialised stores
Overview
Financials
Revenue history (in k)
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 76 days for 2021).
- 202514/07/2026
- 202430/06/2025
- 202316/07/2024
- 202215/07/2023
- 202129/09/2022
- 202005/05/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Authorized Representatives
Manner of representation
The right to represent and conduct the affairs of the company is vested solely in the partners with unlimited liability (general partner). The method of representation of the general partner–the company operating under the name Apteka Portowa spółka z ograniczoną odpowiedzialnością with its registered office in Szczecin–is as follows: each member of the management board or the commercial proxy appointed by the management board is authorised to make declarations of will concerning the company’s property rights and obligations and to sign agreements and obligations on behalf of the company independently. Composition of the management board of the company operating under the name Apteka Portowa spółka z ograniczoną odpowiedzialnością with its registered office in Szczecin: President of the Management Board – Łukasz Knopf.
Partners
| Partners |
|---|
Apteka Portowa Sp. z o.o. |
Aleksander Knopfage 72 |
Łukasz Knopfage 44 |
Squashme Sp. z o.o. |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2012-02-13.
23 1940 1076 3177 9269 0000 0000
34 1240 3826 1111 0010 6279 6997
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 5,261PLN 5,261 |
Public aid
6 public aid cases recorded, with a total value of $108,106.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Feb 25, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $2,382$2,382 | Polska Fundacja Przedsiębiorczości | |
| Jan 29, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $2,420$2,420 | Polska Fundacja Przedsiębiorczości | |
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $4,167$4,167 | Prezes Zakładu Ubezpieczeń Społecznych |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Fragalsp. z o.o. | $5,374,285.81 | aptekafragal.pl | ||
| Modrzewscysp. j. | $5,602,358.99 | aptekacentrum.lublin.pl | ||
| Ms-Pharmsp. z o.o. + limited partnership | $4,619,501.46 | mspharm.pl | ||
| Farmjug Agsp. z o.o. | $4,213,734.86 | farmjug.pl | ||
| MagmaxS.A. | $4,200,912.15 | magmaxsa.pl | ||
| Adpharmasp. z o.o. | $4,026,799.19 | adamed.com | ||
| Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j. | $3,414,382.70 | aptekazielona.com.pl | ||
| Novopharm - Millersp. j. | $2,839,228.36 | apteka.zyj-zdrowo.com | ||
| Eurekasp. z o.o. | $1,377,733.77 | fundacja-eureka.edu.pl | ||
| Przedsiębiorstwo Zaopatrzenia Farmaceutycznego Cefarm-SzczecinS.A. | – | farmacol.com.pl |
FAQ
Last updated: 2026-07-23